Evaluation of the antibacterial activity of bee venom from different sources

World Applied Sciences Journal

Volumn 30, Issue 3, 2014, Pages 266-270

  Hegazi, Ahmed ^a   Abdou, Amr M ^a   El Moez, S I ^a   Allah, Fyrouz Abd ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Antimicrobial Activity; Apis mellifera; Bee Venom

Indexed keywords

EID: 84894504492     PISSN: 18184952     EISSN: 19916426     Source Type: Journal    
DOI: 10.5829/idosi.wasj.2014.30.03.82215     Document Type: Article

References (36)

1. Banks, B.E.L. and R.A. Shipolini, 1986. Chemistry and pharmacology of honey-bee venom. In: T. Ipek, (Ed.), Venoms of the Hymenoptera. Academic Press, pp: 330-403.
2. Potts, B.C.M., D.J. Faulkner, M.S. de Carvalho and R.S. Jacobs, 1992. The chemical mechanism of inactivation of bee venom phospholipase A2 by the marine natural products manoalide, luffarielloide and scalaradial. J. Am. Chem. Soc., 114: 5093-5100.
3. Palma, M.S. and M.R. Brochetto-Braga, 1993. Biochemical variability between venoms from different honey-bee (Apis mellifera) races. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology, 106(2): 423-427.
4. Habermann, E., 1972. Bee and wasp venoms: the biochemistry and pharmacology of their peptides and enzymes are reviewed. Science, 177: 314-322.
5. Dotimas, E.M. and R.C. Hider, 1987. Honeybee venom. Bee World, 68(2): 51-70.
6. Hegazi, A.G., 2009. Role of cytokines in bee venom therapy-Part I. Apitherapy Review, Issue 3.
7. Hegazi, A.G., 2012. Medical importance of bee products. ARI BLM / BEE SCIENCE, 12(4): 136-146.
8. Shaposhnikova, V.V., L.N. Kublik, A.A. Narimanov, M.K.H. Levitman, O.E. Orlova, A.A. Kudriavtsev, V.V. Leshchenko and Iu. N. Korystov, 2001. Growth inhibition and induction of tumor cell death by phospholipase A2 and lipoxygenase inhibitors. Izvestiia Akademii Nauk. Seriia Biologicheskaia, (2): 249-252.
9. Orsoliæ, N., L. Sver, S. Verstovsek, S. Terziæ and I. Basiæ, 2003. Inhibition of mammary carcinoma cell proliferation in vitro and tumor growth in vivo by bee venom. Toxicon, 41(7): 861-870.
10. Lee, J.D., H.J. Park, Y. Chae and S. Lim, 2005. An overview of bee venom acupuncture in the treatment of arthritis: eCAM, 2(1): 79-84.
11. Son, D.J., J.W. Lee, Y.H. Lee, H.S. Song, C.K. Lee and J.T. Hong, 2007. Therapeutic application of anti-arthritis, pain-releasing and anti-cancer effects of bee venom and its constituent compounds. Pharmacology and Therapeutics, 115(2): 246-270.
12. Berman, B.M., J.P. Swyers and J. Ezzo, 2000. The evidence for acupuncture as a treatment for rheumatologic conditions. Rheum. Dis. Clin. North Am., 26(1): 103-115.
13. Harwig, S.S., L. Tan, X.D. Qu, Y. Cho, P.B. Eisenhauer and R.I. Lehrer, 1995. Bactericidal properties of murine intestinal phospholipase A2. The Journal of Clinical Investigation, 95(2): 603-610.
14. Koduri, R., J. Gronroos, V. Laine, C. Le Calvez, G. Lambeau, T. Nevalainen and M. Gelb, 2002. Bactericidal properties of human and murine groups I, II, V, X and XII secreted phospholipases A2. The Journal of Biological Chemistry, 277(8): 5849-5857.
15. Boutrin, M.C., H.A. Foster and V.W. Pentreath, 2008. The effects of bee (Apis mellifera) venom phospholipase A2 on Trypanosoma brucei brucei and enterobacteria. Experimental Parasitology, 119(2): 246-251.
16. Park, S., B. Park, S. Yun, H. Kang, B. So and S. Yun, 2013. Antimicrobial activities of honey bee venom against pathogens isolated from clinical bovine mastitis in Korea. Planta Med., 79-PL16
17. Hegazi, A.G., N.Z. Moharram, F.A. Abd-Allah, M.S. Nour and A.M. Khair, 2002. Antibacterial activity of different Egyptian honeys in relation to some bee products. Egypt. J. Vet. Sci., 36: 31-42.
18. Finegold, S.M. and E.E. Sweeny, 1961. New selective differential medium for coagulase positive staphylococci allowing rapid growth and strain differentiation. J. Bacteriol., 81: 636-641.
19. Cruickshank, R., J.P. Duguid, B.P. Masion and R.H. Swain, 1979. Medical Microbiology. 12th ed., Churchill Livingstone, Edinburgh, London, New York.
20. Wu, M. and R.E. Hancock, 1999. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J. Biol. Chem., 274(1): 29-35.
21. Hegazi, A.G., F.K. Abd El Hady and F.A. Abd Allah, 2000. Chemical composition and antimicrobial activity of European propolis. Zeitschrift für Naturforschung. C, Journal of Biosciences, 55(1-2): 70-75.
22. Hegazi, A.G. and F.M. Abd Allah, 2012. Antimicrobial Activity of Different Saudi Arabia Honeys. Global Veterinaria, 9(1): 53-59.
23. Steel, R.G.D. and J.H. Torrie, 1980. Principles and Procedures of Statistics: A Biometrical Approach. 2nd ed. McGraw Hill Book Company, New York.
24. Hsiang, H.K. and W.B. Elliott, 1975. Differences in honeybee (Apis mellifera) venom obtained by venom sac extraction and electrical milking. Toxicon., 13: 145-148.
25. Lariviere, W.R. and R. Melzack, 1996. The bee venom test: a new tonic-pain test. Pain, 66(2-3): 271-277.
26. Kwon, Y.B., H.J. Lee, H.J. Han, W.C. Mar, S.K. Kang, O.B. Yoon, A.J. Beitz and J.H. Lee, 2002. The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats. Life Sci., 71(2): 191-204.
27. Fennell, J.F., W.H. Shipman and L.J. Cole, 1968. Antibacterial action of melittin, a polypeptide from bee venom. Proc. Soc. Exp. Biol. Med., 127(3): 707-710.
28. Kondo, E. and K. Kanai, 1986. Bactericidal activity of the membrane fraction isolated form phagocytes of mice and its stimulation by melittin. Jpn. J. Med. Sci. Biol., 39(1): 9-20.
29. Ortel, S. and F. Markwardt, 1955. Studies on the antibacterial properties of bee venom. Pharmazie, 10(12): 743-746.
30. Stocker, J.F. and J.R. Traynor, 1986. The action of various venoms on Escherichia coli. J. Appl. Bacteriol., 61(5): 383-388.
31. Perumal Samy, R., P. Gopalakrishnakone, M.M. Thwin, T.K. Chow, H. Bow, E.H. Yap and T.W. Thong, 2007. Antibacterial activity of snake, scorpion and bee venoms: a comparison with purified venom phospholipase A2 enzymes. J. Appl. Microbiol., 102(3): 650-659.
32. Benton, A.W. and L. Mulfinger, 1989. Methods and compositions for the treatment of mammalian infections employing medicaments comprising Hymenoptera venom or proteinaceous polypeptide components thereof. USA Patent, US 4 822 608, pp: 39.
33. Rybak, C.H., T. Szczesna, M. Rybak and A. Pidek, 1994. Some properties of honey bee venom. Pszczelnicze Zeszyty Naukowe, 38: 85-90.
34. Han, S.M., K.G. Lee, K.Y. Park and S.C. Pak, 2013. Antimicrobial Activity of Honey Bee Venom against Select Infectious Fish Pathogens. North American Journal of Aquaculture, 75(3): 445-448.
35. Han, S., K.G. Lee, J.H. Yeo, H.Y. Kweon, B.S. Kim, J.M. Kim, H.J. Baek and S.T. Kim, 2007. Antibacterial Activity of the Honey Bee Venom against Bacterial Mastitis Pathogens Infecting Dairy Cows. Int. J. Indust. Entomol., 14(2): 137-142.
36. Monk, J.D., L.R. Beuchat and A.K. Hathcox, 1996. Inhibitory effects of sucrose monolaurate, alone and in combination with organic acids, on Listeria monocytogenes and Staphylococcus aureus. J. Appl. Bacteriol., 81(1): 7-18.